Australia markets open in 5 hours 36 minutes

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3963+0.0325 (+8.93%)
As of 02:24PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 11.34M
Enterprise value -33.13M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.50
Price/book (mrq)0.28
Enterprise value/revenue -4.51
Enterprise value/EBITDA 0.38

Trading information

Stock price history

Beta (5Y monthly) 1.97
52-week change 3-91.37%
S&P500 52-week change 3-3.35%
52-week high 35.2000
52-week low 30.3500
50-day moving average 30.5834
200-day moving average 31.9827

Share statistics

Avg vol (3-month) 3334.85k
Avg vol (10-day) 3175.64k
Shares outstanding 531.48M
Implied shares outstanding 6N/A
Float 821.46M
% held by insiders 111.94%
% held by institutions 141.13%
Shares short (28 Apr 2022) 4332.06k
Short ratio (28 Apr 2022) 41.61
Short % of float (28 Apr 2022) 41.06%
Short % of shares outstanding (28 Apr 2022) 41.05%
Shares short (prior month 30 Mar 2022) 4526.97k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 312 Feb 2017
Ex-dividend date 419 Aug 2015
Last split factor 21:15
Last split date 312 Feb 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin 0.00%
Operating margin (ttm)-1,140.99%

Management effectiveness

Return on assets (ttm)-69.54%
Return on equity (ttm)-150.11%

Income statement

Revenue (ttm)7.34M
Revenue per share (ttm)0.24
Quarterly revenue growth (yoy)20.10%
Gross profit (ttm)-64.91M
EBITDA -83.44M
Net income avi to common (ttm)-87.93M
Diluted EPS (ttm)-2.8700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.85M
Total cash per share (mrq)1.49
Total debt (mrq)2.38M
Total debt/equity (mrq)5.80
Current ratio (mrq)3.63
Book value per share (mrq)1.31

Cash flow statement

Operating cash flow (ttm)-83.75M
Levered free cash flow (ttm)-48.89M